Published: 2017-10-28

Psychiatric morbidity in newly diagnosed carcinoma cervix and its comparison with benign condition

Rajnish Raj, Nisha Bhagat


Background: To study the psychiatric morbidity among newly diagnosed carcinoma cervix and its comparison with benign gynaecological diseases of cervix. Cervical cancer is the second most common cancer in the world and ranked first in India. It is mainly caused by sexually transmitted infection (STI) of human papilloma virus (HPV).

Methods: It was an open labeled, cross-sectional and extended phase study that screened 158 patients in the age group of 18-70 years who fulfilled both inclusion and exclusion criteria and screened positive on liquid based cytology (LBC), as per guidelines of Bathesda system in Government Medical College, Patiala. 13 patients dropped out of study and finally 145 patients were enrolled. They were further divided after biopsy into two groups as per histopathological examination (HPE) i.e., Group-1, N=47 women HPE positive for cervical intraepithelial neoplasia (CIN) as Cases and Group-2, N=98 HPE negative as Control Hospital Anxiety Depression Scale (HADS) was used to screen psychiatric morbidity for depression and anxiety. Whereas, severity was assessed on Hamilton Rating Scale for Depression (HAM-D) and Hamilton Rating Scale for Anxiety (HAM-A).

Results: Mean age of Group-1 was 38.45±11.22 SD years and Group-2 was 36.67±8.54 SD years. Psychiatric morbidity in Group-1 was 65.95% whereas Group-2 was 21.42%. P value obtained on comparing HADS score of two groups was significant (p <0.050). After active intervention there was a significant reduction in psychiatric morbidity of two groups (72% in Group-1 and 81.3% in Group-2).

Conclusions: The study revealed that the breaking of bad news has a significant psycho-social impact on patients suffering from carcinoma cervix than benign group.


Hospital anxiety depression scale (HADS), Cervical intraepithelial neoplasia (CIN), Hospital Hamilton rating scale for depression (HAM-D), Hamilton rating scale for anxiety (HAM-A), International classification of diseases (ICD-10)

Full Text:



Kaarthigeyam K. Cervical cancer in India and HPV vaccination. Indian J Med Pediatric Oncol. 2012;33:7-12.

Yang YL, Liu L, Wang Y, Wu H, Yang XS, Wang JN, Wang L. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:393.

Marteau TM. The psychological costs of screening. BMJ. 1989;299:527.

Derogatis RL, Wise TM. Anxiety and Depressive Disorders in Medical Patients. Washington: American Psychiatric Press;1989.

Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR et al. Epigenetic programming by maternal behavior. Nat Neurosci. 2004; 7(8): 847-54.

Kahneman D. Thinking fast and slow. New York: Farrar, Straus & Giroux; 2011.

Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP. Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer. 2004;101:404-11.

De Bock GH, Bonnema J, Zwaan RE, Van De Velde CJH, Kievit J, Stiggelbout AM. Patient’s needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer. 2004;90:1144-50.

Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand. 1983;67:361-70.

Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A et al. Major depression in outpatients attending a regional cancer centre: Screening and unmet treatment needs. Br J Cancer. 2004;90:314-20.

Mykletun A, Stordal E, Dahl AA. The Hospital Anxiety and Depression Scale (HADS): Factor structure, item analyses, and internal consistency in a large population. Br J Psychiatry. 2001;179:540-4.

Walker J, Postma K, McHugh GS, Rush R, Coyle B, Strong V et al. Performance of the Hospital Anxiety and Depression Scale (HADS) as a screening tool for major depressive disorder in cancer patients. J Psychosom Res. 2007;63:83-9.

Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R et al. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry. 1991;158:255-9.

Soloman D. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute workshop in Bethesda, MD, December 12-13, 1988. Diagn Cytopathol. 1989;5(3):331-4.

Mykletun A, Stordal E, Dahl A. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001;179:540-4.

World Health Organization. International statistical classification of disease and related health problems (10th edn) ICD-10. Geneva; 1994.

Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.

Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997; 73(3): 159-71.

Selye H. The stress of life. New York: McGraw-Hill;1956.

Holroyd K, Lazarus R. Stress, coping and somatic adaptation. In: Goldberger L, Breznitz S, editors. Handbook of stress: theoretical and clinical aspects. New York: The Free Press; 1982:21-35.

Holmes TH, Rahe RH. The Social Readjustment Rating Scale. J Psychosom Res. 1967;11(2):213-8.

Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer. 1995;76(10 Suppl):1888-901.

James W. What is an emotion? Mind. 1884;9:188-205.

Cannon WB. Bodily changes in pain, hunger, fear and rage. New York: D. Appleton & Co;1927.

Schachter S, Singer J. Cognitive, social and physiological determinants of emotional state. Psychol Rev. 1962;69(5):379-99.

Vistad I, Fossa SD, Dahl AA. A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecol Oncol. 2006;102:563-72.

Lloyd-Williams M, Shiels C, Taylor F, Dennis M. Depression: an independent predictor of early death in patients with advanced cancer. J Affect Disord. 2009; 113(1-2): 127-32.

Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A et al. Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol. 2009;71(3):299-303.

Hashimoto N, Isaka N, Ishizawa Y, Mitsui T, Sasaki M. Surgical management of colorectal cancer in patients with psychiatric disorders. Surgery. 2009;39(5):393-8.

Alexander PJ, Dinesh N, Vidyasagar MS. Psychiatric morbidity among cancer patients and its relationship with awareness of illness and expectations about treatment outcome. Acta Oncologica. 1993;32:623-4.

Mishra SK, Mohapatra PK, Bhattacharya K, Gupta T, Agarwal JP. Prevalence of psychiatric disorder in asymptomatic or minimally symptomatic cancer patients on treatment. J Cancer Res Therapeut. 2006;2:136-9.

Mendonsa RD, Appaya P. Psychiatric morbidity in outpatients of gynecological oncology clinic in a tertiary care hospital. Indian J Psychiatry. 2010;52(4):327-32.

Lau KL, Yim PH, Cheung EY. Psychiatric morbidity in Chinese women after cervical cancer treatment in a regional gynaecology clinic. East Asian Arch Psychiatry. 2013 Dec;23(4):144-53.